Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating expenses:
Research and development expenses	$ 1,413,057	$ 1,971,679
General and administrative expenses	1,636,216	2,060,148
Total operating expenses	3,049,273	4,031,827
Loss from operations	(3,049,273)	(4,031,827)
Other income
Interest income	655	46,419
Net loss	(3,048,618)	(3,985,408)
Comprehensive loss	$ (3,048,618)	$ (3,985,408)
Per share information:
Net loss per share, basic (in dollars per share)	$ (0.14)	$ (0.39)
Net loss per share, diluted (in dollars per share)	$ (0.14)	$ (0.39)
Weighted average common shares outstanding, basic (in shares)	22,263,838	10,314,761
Weighted average common shares outstanding, diluted (in shares)	22,263,838	10,314,761